Our understanding and management of atypical hemolytic uremic syndrome (aHUS) have
dramatically improved in the last decade. aHUS has been established as a prototypic …

Simple Summary It is being increasingly recognized that patients with monoclonal
gammopathy (MG) who do not meet criteria for malignant disease and treatment initiation …

Background Due to the various clinical and pathological manifestations of kidney
involvement in lymphoproliferative disorder (LPD), the whole spectrum of kidney disease in …

Thrombotic microangiopathies (TMA) are usually associated with hematological features
(RH-TMA). The epidemiology of TMA limited to kidneys (RL-TMA) is unclear Therefore …

Background Recent studies showed a high prevalence of monoclonal gammopathy (MG) in
patients with thrombotic microangiopathy (TMA) aged over 50 years and suggested that …

Plasma cell dyscrasias are a subset of hematological malignancies involving the production
of monoclonal immunoglobulins. This spectrum of disorders includes asymptomatic …

Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series -
Vitkauskaitė - 2022 - Clinical Case Reports - Wiley Online Library Skip to Article Content Skip …

Thrombotic microangiopathy (TMA) secondary to anticancer drugs exhibits varying
clinicopathological presentation and severity, with variable response and prognosis upon …

Monoklonální gamapatie nejistého významu (MGUS) je charakterizována přítomností
monoklonálního imunoglobulinu (M-Ig) bez průkazu přítomnosti mnohočetného myelomu …

Monoclonal gammopathy of renal significance (MGRS) is a group of pathologies that
includes all kidney disorders related to a monoclonal protein in patients without diagnostic …